SURVEILLANCE
EU-JAMRAI 2 works on improving surveillance of AMR in human health, animal health and the environment as well as from a One Health perspective.
The activities are designed to provide added value to the current surveillance landscape and to reinforce the European strategy for One Health surveillance of AMR. The goal is to fill some of the current surveillance gaps for AMR and to create a strong connection between policy and implementation of prioritised activities.
The majority of our partners are national governmental agencies and national expert laboratories. In total, 25 countries are involved. Our main stakeholders are EU and UN agencies such as ECDC, EFSA, EEA and WHO Europe.
How does the One Health surveillance work performed in EU-JAMRAI 2 support the implementation of the EU Council recommendation of AMR?
The surveillance work of EU-JAMRAI 2 supports the following recommendations:
- Developing integrated systems for the surveillance of AMR and AMC encompassing human health, animal health, plant health, food, wastewater and the environment […](5e).
- Continue to assess on the basis of EFSA opinions animal diseases caused by bacteria resistant to antimicrobials, to ascertain if it is needed to list any of those diseases in Regulation (EU) 2016/429(57) with a view to categorising them for any regulatory surveillance, control or other management measures (6).
- Guidelines for the treatment of common infections (11.a and supporting 13)
- Pathogens resistant to last line treatments are notifiable diseases under national legislation (5.b)
- Expand human AMR surveillance by including more specimen types (in addition to blood samples) (5.a)
Other policy documents of importance for the surveillance work of EU-JAMRAI 2:
- UNGA Political Declaration: A global commitment to combat antimicrobial resistance.
- Design of a monitoring framework for EU AMR policies.
- Individual countries’ National Action Plans.
Human Health
EU-JAMRAI 2 works to strengthen the national systems for microbiological surveillance of AMR in the human sector.
Our vision is: “A Europe where every country has the capacity to perform, contribute to and benefit from high-quality, harmonised antibiotic resistance surveillance, regardless of size or resources.”
Animal Health
The European AMR surveillance network in veterinary medicine (EARS-Vet) was initiated during EU-JAMRAI 1 to enhance AMR surveillance in bacterial pathogens of animals (i.e., in diseased animals).
Environment health
The Joint Action will promote the work of AMR surveillance in the Environment, strengthening collaboration through a professional network (EARS-Env) and aligning efforts with other sectors and initiatives.
National One Health reports
EU-JAMRAI 2 will map and evaluate the One Health-ness of national surveillance systems, including aspects of AMR/AMC data accessibility and data quality, and formulate common suggestions for improvements. It will facilitate the development of One Health surveillance reports in participating countries and the creation of interactive dashboards to visualise surveillance data to inform policy actions.